Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
- APPROACH Study Group
Research output: Contribution to journal › Article › peer-review
91
Link opens in a new tab
Scopus
citations